The company and the founder are revenge, reflecting the dilemma of China's innovative pharmaceutical industry

On August 17, the industry suddenly reported that the founder of the legendary creature of Nanjing Kingsuri creatures and Fan Xiaohu, who had resigned.

Fan Xiaohu is the co -founder of the legendary creature, and was the company's chief scientific official before leaving. In 2014, Fan Xiaohu, as the number one employee of the legendary creature, led the team to formally stripped separately from Kim Sirui and focused on CAR-T cell therapy.

It took 8 years before and after, the legendary BCMA target CAR-T cell immunotherapy was successfully approved to go public in the United States at the end of February this year, becoming the first CAR-T product in China to enter the US market.

Unexpectedly, after the departure of Fan Xiaohu at the end of March of this year, he had a lawsuit of "infringing business secrets" in less than half a year.

Before that, Fan Xiaohu, the English name of Frank, caused a small trouble.

On April 16, 2019, the legendary creature, Jiangsu Provincial People's Hospital, and Shanghai Long March Hospital jointly organized a press conference to introduce the clinical progress of CAR-T. At the round table dialogue at the scene, Dr. Frank talked about High ...

In order to carry out overseas promotion, the legendary creature signed an agreement with Yangsen in the United States at the end of 2017 to jointly develop CAR-T drugs Sidaki Olun. At that time, the data announced at the time was only $ 350 million in advance, and the subsequent total payment amount was not mentioned.

Dr. Frank said that he had talked about the specific amount of subsequent payment, and was caught by the sensitive media to calculate the legendary creature to make a lot of money. The board of directors of Kingsrui saw the information was a bit unhappy. In July 2019, a announcement was issued in July 2019, directly pointing out that Fan Xiaohu did not participate in commercial negotiations, did not know the follow -up payment data, and reminded Fan Xiaohu "strictly strictly Disclosure according to the announcement. "

It is said that the scientific research team of the legendary creature was brought by the chief scientist Fan Xiaohu, and the legendary creature is conducting the research of car-T for physical tumors. Fan Xiaohu's departure and complaining of this series of incidents may reflect the internal contradictions of legendary creatures and Kingsley.

Over the past year, the back and forth of the executives of innovative pharmaceutical companies have been flowing back and forth, so that the outside world can not see which links are in the end. Many people directly blame: the innovative pharmaceutical industry is not good.

Innovation is not easy, especially in the cold winter of capital, the entrepreneurial team that can stick to the group is more difficult. When the wind was smooth and the water, everyone was waiting for the IPO to increase its value. Nowadays, the world has changed, survival is difficult, and all kinds of crickets have been enlarged. However, most of the time, scientists are to stay in the first line. In the future, they will meet each other, and they are rare to the public.

In the future, such disputes may be more and more. The water retreated, all muddy.

Writing | Jia Ting

Edit | Jiang Yun

Operation | Valley

Illustration | Visual China

#Fan Xiaohu ## Legendary creature#

- END -